Aortik Kapak Hastalıklarında Sezaryen Anestezisi
Özet
Gebelikte kardiyovasküler hastalıklar, maternal morbidite ve mortalitenin önde gelen nedenleri arasında yer almakta olup romatizmal kapak hastalıkları sıklıkla görülmektedir. Aortik kapak hastalıklarından aort darlığı (AD) ve aort yetersizliği (AY), sezaryen anestezisinde multidisipliner, kişiselleştirilmiş ve hemodinamik açıdan son derece titiz bir yaklaşım gerektirir. Ciddi AD bulunan gebelerde temel hemodinamik hedefler; sinüs ritminin ve normal kalp hızının korunması, yeterli hidrasyonun sağlanması ile sistemik vasküler direncin sürdürülerek miyokardiyal iskemiyi önlemek adına hipotansiyondan kaçınılmasıdır. Hipotansiyon geliştiğinde ilk tercih saf alfa-agonist fenilefrin olmalı, taşikardiye yol açan ilaçlardan ve hızlı sempatektomi riski taşıyan tek başına spinal anesteziden kesinlikle kaçınılmalıdır. Kalp yetmezliği ve instabilitesi olan AD hastalarında genel anestezi altın standart kabul edilirken, stabil olgularda yavaş titre edilen epidural anestezi tercih edilebilir. Aort yetersizliğinde ise diyastol süresini uzatarak regürjitasyonu artıran bradikardiden kaçınılmalı, kalp hızı dakikada 80-100 aralığında tutulmalı, ard yük ve ön yük düşük seviyede idame ettirilmelidir. AY hastalarında nöroaksiyel anestezi teknikleri ard yükü düşürdüğü için genellikle iyi tolere edilir. Postpartum dönemde uterotonik olarak yavaş infüzyon oksitosin güvenle kullanılırken, koroner vazospazma yol açabilen ergometrin kullanımından kaçınılmalıdır. Tüm bu süreçte hastaların hemodinamik stabilitesini korumak için invaziv arterial ve santral venöz kateterizasyon ile yakın takip ve yoğun bakım izlemi kritik bir role sahiptir.
Referanslar
Berg CJ, Callaghan WM, Syverson C, et al. Pregnancy-related mortality in the United States, 1998 to 2005. Obstet Gynecol. 2010;116:1302-1309.
Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, et al; ESC Scientific Document Group. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J. 2018;39:3165-3241.
Khan KS, Wojdyla D, Say L, et al. WHO analysis of causes of maternal death: A systematic review. Lancet. 2006;367:1066-1074.
Siu SC, Sermer M, Colman JM, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation. 2001;104:515–521.
Swan L. Congenital heart disease in pregnancy. Best Pract Res Clin Obstet Gynaecol. 2014;28(4):495-506.
Rutherford JD. Heart failure in pregnancy. Curr Heart Fail Rep. 2012;9:277-281.
Canobbio MM, Warnes CA, Aboulhosn J, et al; Council on Cardiovascular Disease in the Young; Council on Functional Genomics and Translational Biology; and Council on Quality of Care and Outcomes Research. Management of Pregnancy in Patients with Complex Congenital Heart Disease: A Scientific Statement for Healthcare Professionals from the American Heart Association. Circulation. 2017;135:e50-e87.
Lindley KJ, Conner SN, Cahill AG, et al. Contraception and Pregnancy Planning in Women with Congenital Heart Disease. Curr Treat Options Cardiovasc Med. 2015;17(11):50.
Arendt KW, Lindley KJ. Obstetric anesthesia management of the patient with cardiac disease. Int J Obstet Anesth. 2019;37:73-85.
Thorne S, MacGregor A, Nelson-Piercy C. Risks of contraception and pregnancy in heart disease. Heart. 2006;92:1520-1525.
Ford AA, Wylie BJ, Waksmonski CA, et al. Maternal congenital cardiac disease: outcomes of pregnancy in a single tertiary care center. Obstet Gynecol. 2008;112:828-833.
Maxwell BG, El-Sayed YY, Riley ET, et al. Peripartum outcomes and anaesthetic management of parturients with moderate to complex congenital heart disease or pulmonary hypertension. Anaesthesia. 2013;68:52-59.
Silversides CK, Grewal J, Mason J, et al. Pregnancy Outcomes in Women with Heart Disease: The CARPREG II Study. J Am Coll Cardiol. 2018;71:2419-2430.
Goldszmidt E, Macarthur A, Silversides C, et al. Anesthetic management of a consecutive cohort of women with heart disease for labor and delivery. Int J Obstet Anesth. 2010;19:266-272.
David H. Chestnut. Cardiovascular disease. David H Chestnut, eds. Obstetric Anaesthesia - Principles and Practice. 5th ed. Philadelphia: Elsevier-Saunders; 2014: 960-1002.
Silversides CK, Colman JM, Sermer M, et al. Early and intermediate-term outcomes of pregnancy with congenital aortic stenosis. Am J Cardiol. 2003;91:1386-1389.
Hameed A, Karaalp IS, Tummala PP, et al. The effect of valvular heart disease on maternal and fetal outcome of pregnancy. J Am Coll Cardiol. 2001;37:893-899.
Datt V, Tempe DK, Virmani S, et al. Anesthetic management for emergency cesarean section and aortic valve replacement in a parturient with severe bicuspid aortic valve stenosis and congestive heart failure. Ann Card Anaesth. 2010;13:64-68.
Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2021;143:e35-e71.
Ioscovich AM, Goldszmidt E, Fadeev AV, et al. Peripartum anesthetic management of patients with aortic valve stenosis: a retrospective study and literature review. Int J Obstet Anesth. 2009;18:379-386.
Tzemos N, Silversides CK, Colman JM, et al. Late cardiac outcomes after pregnancy in women with congenital aortic stenosis. Am Heart J. 2009;157:474-480.
Kampman MA, Valente MA, van Melle JP, et al; ZAHARA II investigators. Cardiac adaption during pregnancy in women with congenital heart disease and healthy women. Heart. 2016;102:1302-1308.
Akpinar O. Gebelik ve kapak hastaliklari [Pregnancy and heart valve disease]. Anadolu Kardiyol Derg. 2009;9 Suppl 1:25-34.
Brown J, Morgan‑Hughes NJ. Aortic stenosis and non‑cardiac surgery. Contin Educ Anaesth Crit Care Pain 2005;5(1):1‑4.
Ramanathan S, Grant GJ. Vasopressor therapy for hypotension due to epidural anesthesia for cesarean section. Acta Anaesthesiol Scand. 1988;32(7):559-65.
UpToDate (2021). Anesthesia for labor and delivery in high-risk heart disease: Specific lesions. 20.03.2021 tarihinde https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-specific-lesions#H855740842 adresinden ulaşılmıştır.
UpToDate (2021). Anesthesia for labor and delivery in high-risk heart disease: General considerations. 20.03.2021 tarihinde https://www.uptodate.com/contents/anesthesia-for-labor-and-delivery-in-high-risk-heart-disease-general-considerations?sectionName=Neuraxial%20analgesia%20for%20labor&topicRef=93919&anchor=H77919293&source=see_link#H77919293 adresinden ulaşılmıştır.
UpToDate (2021). Anesthesia for noncardiac surgery in patients with aortic or mitral valve disease. 20.03.2021 tarihinde https://www.uptodate.com/contents/anesthesia-for-noncardiac-surgery-in-patients-with-aortic-or-mitral-valve-disease/print adresinden ulaşılmıştır.
Brian JE Jr, Seifen AB, Clark RB, et al. Aortic stenosis, cesarean delivery, and epidural anesthesia. J Clin Anesth. 1993;5:154-157.
Easterling TR, Chadwick HS, Otto CM, Benedetti TJ. Aortic stenosis in pregnancy. Obstet Gynecol. 1988;72:113-118.
Fanning N, Balki M, Sermer M, et al. Noninvasive cardiac output monitoring during general anesthesia for Cesarean delivery in a patient with severe aortic stenosis. Can J Anaesth. 2011;58:837-841.
Leatherbarrow AC. Management of emergency caesarean section in a patient with decompensated critical aortic stenosis. Journal of Obstetric Anaesthesia and Critical Care. 2018 8(1):50.
Ghosh S, Marton S. Anesthetic management for cesarean delivery in a patient with severe aortic stenosis and severe obesity. Obes Surg. 2011;21:264-266.
Picker O, Schwarte LA, Schindler AW, et al. Desflurane increases heart rate independent of sympathetic activity in dogs. Eur J Anesthesiol. 2003;20(12):945–951.
Hemmerling T, Olivier JF, Le N, et al. Myocardial protection by isoflurane vs. sevoflurane in ultra-fast-track anaesthesia for off-pump aortocoronary bypass grafting. Eur J Anaesthesiol. 2008;25(3):230-236.
Tamhane P, O'Sullivan G, Reynolds F. Oxytocin in parturients with cardiac disease. Int J Obstet Anesth. 2006 Oct;15(4):332-333.
Burt CC, Durbridge J. Management of cardiac disease in pregnancy. Continuing Education in Anaesthesia, Critical Care & Pain. 2009;9:44 47.
Leśniak-Sobelga A, Tracz W, KostKiewicz M, et al. Clinical and echocardiographic assessment of pregnant women with valvular heart diseases--maternal and fetal outcome. Int J Cardiol. 2004;94:15-23.